BioCatalyst

Encorafenib, Binimetinib, Pembrolizumab — catalyst calendar

1 verified catalyst event(s) referencing Encorafenib, Binimetinib, Pembrolizumab, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-30
in 1mo
ESTIMATED
 READOUT
A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrol
Phase 3 · Melanoma
 PFE PFIZER INC Encorafenib, Binimetinib, Pembrolizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.